Add BrightSurf on Google Email

Bioengineered lymph nodes offer window into human immunity

Researchers at NUS have developed a bioengineering approach to keep human lymph node tissue alive and functioning outside the body for several days. The method involves embedding thin slices of lymph node tissue in a soft gel that mimics the body's natural environment, allowing for detailed studies of immune cell behavior.

SourceNational University of Singapore College of Design and Engineering·JournalTrends in Biotechnology·TypeExperimental study·DateSep 10, 2025

Vaccines trigger rapid lymph node responses

Researchers discovered that vaccines induce changes in stromal cells of draining lymph nodes within hours, priming the landscape for immune responses. Different vaccines activate lymph node stromal cells differently, with some inducing specific effects on lymphatic endothelial cells.

SourceUniversity of Turku·JournalScience Immunology·DateAug 18, 2025

CNIO researcher develops a test aimed to detect early-stage tumors with a blood sample

Researchers developed a test to detect early-stage solid tumors using a blood sample, identifying patterns in amino acid concentrations that can translate into diagnostic signals. The test achieved an 87% positive rate and showed potential for precision medicine in choosing treatments.

SourceCentro Nacional de Investigaciones Oncológicas (CNIO)·JournalNature Communications·TypeExperimental study·DateJul 31, 2025

Study uncovers how immune cells contribute to failed bone healing after muscle-bone trauma

Researchers uncovered two myeloid cell populations driving immune dysregulation in polytrauma, highlighting a critical role of TIM cells in immune suppression. The study also identified key genes and communication patterns involved in polytrauma-induced immune responses, providing potential targets for therapeutic intervention.

SourceEditorial Office of West China School of Stomatology, Sichuan University·JournalBone Research·TypeExperimental study·DateJul 21, 2025

A Journal of Intensive Medicine editorial highlights a new metabolic checkpoint in immunity

Researchers discover a novel metabolic pathway, glyoxalase system, that regulates excessive immune responses by targeting a previously underexplored metabolic pathway. The GLO2-SLG-D-lactylation pathway suppresses inflammatory signaling, reducing inflammation in acute and autoimmune disease settings.

SourceJournal of Intensive Medicine·JournalJournal of Intensive Medicine·TypeCommentary/editorial·DateJul 7, 2025

In diseases due to exposure to toxic particles like gout, macrophages elicit separate pathways for inflammation and lysosomal function

Research found that macrophages use two independent pathways to regulate inflammatory and lysosomal responses to toxic particles. The study identified key transcription factors and signaling pathways involved, offering potential therapeutic opportunities to quell inflammation.

SourceUniversity of Alabama at Birmingham·JournalImmunity·TypeExperimental study·DateJun 23, 2025

A combination of exercise and omega-3 reduces the severity of tooth root infections

A study published in Scientific Reports found that a combination of exercise and omega-3 supplementation significantly improves the immune response and reduces the severity of chronic apical periodontitis. The researchers induced apical periodontitis in rats, dividing them into three groups: one received no intervention, while the othe...

Unlocking the secrets of bat immunity

Researchers developed organoids from Egyptian fruit bats' respiratory and intestinal tissue, showcasing a significantly higher baseline antiviral immune activity. These organoids demonstrated an exceptionally strong production of type III interferons, which played a crucial role in mucosal antiviral immunity.

SourceHelmholtz Centre for Infection Research·JournalNature Immunology·TypeExperimental study·DateMay 21, 2025

New findings on T cell exhaustion: The body prepares early for mild to severe disease

A recent study by researchers at TUM has discovered that the body produces special T cells predisposed to exhaustion even in early infection phases of moderate diseases. This finding expands our understanding of immune response mechanisms and could help control the immune system in cancer patients or weaken excessive defenses.

SourceTechnical University of Munich (TUM)·JournalNature·TypeExperimental study·DateApr 7, 2025

Researchers uncover role of fungal circadian clock in pathogenicity

A team of scientists has discovered that the circadian clock plays a crucial role in regulating F. oxysporum's response to zinc starvation and controlling secondary metabolism, enhancing its virulence. The study provides new insight into host-pathogen interactions and could lead to innovative approaches for crop protection.

SourceChinese Academy of Sciences Headquarters·JournalScience Advances·TypeExperimental study·DateApr 3, 2025

Engineering antibodies with a novel fusion protein

Scientists at Sanford Burnham Prebys developed a new method of generating antibodies by fusing two immune system proteins, enabling the creation of stable monoclonal antibodies. This breakthrough has potential applications in diagnosing and monitoring diseases such as lupus and cancers.

SourceSanford Burnham Prebys·JournalJournal of Immunology·TypeExperimental study·DateMar 25, 2025

Researchers find missing link in autoimmune disorder

Scientists have identified a key component in launching immune activity and overactivity, providing a potential target for therapies that could prevent debilitating illnesses. The researchers discovered a protein in cells that spurs the release of infection-fighting molecules, which is essential for controlling the disease.

SourceWashU Medicine·JournalCell·TypeExperimental study·DateMar 18, 2025

Dr. Theodore Scott Nowicki awarded $4.5M NCI grant to advance next generation of cellular immunotherapies for solid tumors

Dr. Nowicki's team has engineered 'supercharged' T cells that produce extra TNF-alpha to boost cancer-fighting ability, offering a potentially more precise and toxic-free treatment option. The new funding will help test these enhanced T cells in preclinical models to evaluate their effectiveness.

No place like home—how proteins that plasma cells express at their origin affect migration

A recent study published in the Journal of Experimental Medicine reveals that plasma cells are programmed from birth to migrate to protected sites in the body, where they produce large amounts of antibodies. High expression of integrin β7 is an excellent marker for these cells' ability to home to the bone marrow.

SourceOsaka University·JournalJournal of Experimental Medicine·TypeExperimental study·DateMar 11, 2025